SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-081157
Filing Date
2022-12-20
Accepted
2022-12-20 09:12:09
Documents
15
Period of Report
2022-12-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea170511-8k_aditxtinc.htm   iXBRL 8-K 32741
2 AT THE MARKET OFFERING AGREEMENT DATED DECEMBER 20, 2022 BETWEEN ADITXT, INC. AN ea170511ex1-1_aditxtinc.htm EX-1.1 202348
3 OPINION OF SHEPPARD, MULLIN, RICHTER & HAMPTON LLP ea170511ex5-1_aditxtinc.htm EX-5.1 15801
4 GRAPHIC ex5-1_001.jpg GRAPHIC 3300
  Complete submission text file 0001213900-22-081157.txt   488362

Data Files

Seq Description Document Type Size
5 XBRL LABEL FILE adtx-20221220_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE adtx-20221220_pre.xml EX-101.PRE 22355
7 XBRL SCHEMA FILE adtx-20221220.xsd EX-101.SCH 3221
9 EXTRACTED XBRL INSTANCE DOCUMENT ea170511-8k_aditxtinc_htm.xml XML 3693
Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Filer) CIK: 0001726711 (see all company filings)

IRS No.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39336 | Film No.: 221472980
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences